Risk Factors and Response to Treatment of Chronic Migraine Patient
Journal Title: European Archives of Medical Research - Year 2020, Vol 36, Issue 3
Abstract
Objective: Migraine is a common cause of medical consultation in neurology policlinics. Chronic migraine usually develops as a complication of episodic migraine. It causes significant distress with substantial impact on the quality of life of an individual and huge economic cost to the society through occupational disability and healthcare consultations. Chronic migraine and medication-overuse headache often coexist. The aim of this study was to determine the risk factors for the transformation to chronic migraine and treatment for chronic migraine. Methods: One hundred thirty-nine patients diagnosed with chronic migraine between January 2014-January 2015 were included in the study. These patients were observed for risk factors and prophylactic treatment. Results: 92.8% of the patients in the study were female and were between the ages of 18-63. 85% of patients had headache for more than five years. Risk factors for the transformation from episodic to chronic migraine were determined as low-level of education, low-middle social economic status, emotional stress, obesity and sleep disorders. All patients were treated with prophylactic treatment. 19 patients were not evaluated because they failed to follow the protocol of treatment. 72% of patients responded to treatment and 27.5% of patients failed treatment. It was determined that only the accompanying depression had a negative effect on treatment response. Conclusion: In our study, female gender, low educational level, low-middle socioeconomic level, obesity, preobesity, comorbid psychiatric disease and analgesic overuse have been shown as risk factors for the transformation from episodic to chronic migraine. Prophylactic drugs used in the treatment of episodic migraine had similar rates of response to treatment when used in chronic migraine prophylaxis. Treatment with botulinum toxin A and dry needle therapy used in the treatment-resistant patient has been shown to significantly increase treatment compliance and response. The presence of depression has been shown to negatively affect treatment.
Authors and Affiliations
Barış Kıran, Onur Akan, Serap Üçler
Keywords
Related Articles
- EP ID EP688689
- DOI 10.4274/eamr.galenos.2020.41736
- Views 138
- Downloads 0
The Effect of Postmastectomy Radiotherapy on Patients with Breast Cancer
Objective: Breast cancer is one of the most common types of cancer in women, and the first-line treatment for it is surgery. Depending on the patient’s condition, either of the following may be selected: breast-conservin...
Extracorporeal Membrane Oxygenation Support on Acute Fulminant Myocarditis Associated with Parainfluenza Infection: A Case Report
Acute fulminant myocarditis (AFM) is a clinical condition that can lead to sudden onset of rapidly progressing cardiogenic shock with significant arrhythmia and possible cardiac arrest. Mechanical circulation support has...
Comparison of Short-term Efficacy of Ranibizumab to Dexamethasone in the Treatment Naive Pseudophakic Diabetic Macular Edema: A Real-Life Study
Objective: This study aimed to compare the short-term efficacy of dexamethasone (Dex) implant with those of three consecutive ranibizumab (Rzb) injections in the treatment-naive diabetic macular edema patients. Methods:...
New Developments in Oncological Treatment: Targeted Treatments and Immunotherapy
In the last 20 years, when we started to understand cancer biology better, targeted therapies and immunotherapies have been developed in systemic treatments and they have started to take their place as monotherapy or com...
Sarcomatoid Carcinoma of the Urinary Bladder: A Case Report and Review of the Literature
Sarcomatoid variant of urothelial carcinoma of the urinary bladder is a rare malignant neoplasm, which is defined with biphasic neoplasm with both an epithelial and a mesenchymal component by histopathological and immuno...